95 related articles for article (PubMed ID: 9914980)
1. [Class M immunoglobulins from blood serum of patients with systemic lupus erythematosus effectively cleave RNA].
Andrievskaia OA; Buneva VN; Zabara VG; Naumov VA; Iamkovoĭ VI; Nevinskiĭ GA
Mol Biol (Mosk); 1998; 32(5):908-15. PubMed ID: 9914980
[No Abstract] [Full Text] [Related]
2. Catalytic heterogenity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus.
Andrievskaya OA; Buneva VN; Naumov VA; Nevinsky GA
Med Sci Monit; 2000; 6(3):460-70. PubMed ID: 11208354
[TBL] [Abstract][Full Text] [Related]
3. [Proteolytic activity of blood serum IgG in patients with systemic lupus erythematosis].
Kit IuIa; Mahorivs'ka IR; Havryliuk AM; Chhop'iak VV; Bilyĭ RO; Stoĭka RS
Ukr Biokhim Zh (1999); 2009; 81(3):77-83. PubMed ID: 19877432
[TBL] [Abstract][Full Text] [Related]
4. RNA-hydrolyzing antibodies from peripheral blood of patients with lupus erythematosus.
Vlassov AV; Andrievskaya OA; Kanyshkova TG; Baranovsky AG; Naumov VA; Breusov AA; Giege R; Buneva VN; Nevinsky GA
Biochemistry (Mosc); 1997 May; 62(5):474-9. PubMed ID: 9275287
[TBL] [Abstract][Full Text] [Related]
5. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA.
Baranovskii AG; Kanyshkova TG; Mogelnitskii AS; Naumov VA; Buneva VN; Gusev EI; Boiko AN; Zargarova TA; Favorova OO; Nevinsky GA
Biochemistry (Mosc); 1998 Nov; 63(11):1239-48. PubMed ID: 9864461
[TBL] [Abstract][Full Text] [Related]
6. [Interaction of catalytically active antibodies with oligoribonucleotides].
Buneva VN; Andrievskaia OA; Romannikova IV; Gololobov GV; Iadav RP; Iamkovoĭ VI; Nevinskiĭ GA
Mol Biol (Mosk); 1994; 28(4):738-43. PubMed ID: 7990801
[TBL] [Abstract][Full Text] [Related]
7. [Changes of immunological homeostasis in erythematosis].
Glavinskaia TA; Dobrotina NA; Komarova VD
Vestn Dermatol Venerol; 1975 May; (5):12-7. PubMed ID: 1146401
[No Abstract] [Full Text] [Related]
8. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
[TBL] [Abstract][Full Text] [Related]
9. [Isolation and characteristics of catalytic antibodies to DNA in systemic lupus erythematosis].
Gololobov GV; Bogomolova AE; Iadav RP; Ermolaeva MV; Belostotskaia KM; Prokaeva TB; Shuster AM; Gabibov AG
Biokhimiia; 1993 Feb; 58(2):313-8. PubMed ID: 8485221
[TBL] [Abstract][Full Text] [Related]
10. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
[TBL] [Abstract][Full Text] [Related]
11. [The effect of monocytes on in vitro synthesis of immunoglobulins and anti-single-stranded DNA antibodies in patients with systemic lupus erythematosus].
Okawa M; Aotsuka S; Yokohari R
Arerugi; 1982 Dec; 31(12):1194-204. PubMed ID: 7171315
[No Abstract] [Full Text] [Related]
12. Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus.
Andrievskaya OA; Buneva VN; Baranovskii AG; Gal'vita AV; Benzo ES; Naumov VA; Nevinsky GA
Immunol Lett; 2002 May; 81(3):191-8. PubMed ID: 11947924
[TBL] [Abstract][Full Text] [Related]
13. [Features of tRNA hydrolysis by autoantibodies from blood serum of patients with certain autoimmune and virus diseases].
Vlasov AV; Helm M; Naumov VA; Breusov AA; Buneva VN; Florentz C; Giege R; Nevinskiĭ GA
Mol Biol (Mosk); 1999; 33(5):866-72. PubMed ID: 10579192
[No Abstract] [Full Text] [Related]
14. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance.
Staropoli JF; Van Cott EM; Makar RS
Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345
[TBL] [Abstract][Full Text] [Related]
15. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
16. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus.
Rothschild BM
J Rheumatol; 2001 Feb; 28(2):455. PubMed ID: 11246696
[No Abstract] [Full Text] [Related]
17. Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice.
Andryushkova AA; Kuznetsova IA; Orlovskaya IA; Buneva VN; Nevinsky GA
Int Immunol; 2009 Aug; 21(8):935-45. PubMed ID: 19556305
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of serum gamma globulins in systemic lupus erythematosus].
Preobrazhenskiĭ DV; Astakhova TA; Barbot'ko ML
Ter Arkh; 1980; 52(6):67-71. PubMed ID: 7404391
[No Abstract] [Full Text] [Related]
19. [Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis].
Vlasov AV; Baranovskiĭ AG; Kanyshkova TG; Prints AV; Zabara VG; Naumov VA; Breusov AA; Giege R; Buneva VN; Nevinskiĭ GA
Mol Biol (Mosk); 1998; 32(3):559-69. PubMed ID: 9720080
[No Abstract] [Full Text] [Related]
20. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
